Philip L. Riches

SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout

Véronique Vitart, Igor Rudan, Caroline Hayward et al. · Nature Genetics · 2008 · 806 citations

Pharmacy, Nephrology, Physiology +13

Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial

Isla S. Mackenzie, Ian Ford, George Nuki et al. · The Lancet · 2020 · 342 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +10

Prevalence and clinical prediction of osteoporosis in a contemporary cohort of patients with rheumatoid arthritis

Barbara Hauser, Philip L. Riches, James F. Wilson et al. · Lara D. Veeken · 2014 · 159 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +17

Proteins secreted by the parasitic nematodeNippostrongylus brasiliensis act as adjuvants for Th2 responses

Martin J. Holland, Yvonne Harcus, Philip L. Riches et al. · European Journal of Immunology · 2000 · 139 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Osteoporosis Associated with Neutralizing Autoantibodies against Osteoprotegerin

Philip L. Riches, Euan McRorie, William D. Fraser et al. · New England Journal of Medicine · 2009 · 118 citations

Medicine, Immunology, Pathology +17